期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

醛固酮受体拮抗剂抗氧化及对糖尿病肾病保护作用 被引量：5

下载PDF
导出
摘要 糖尿病肾病（diabetic nephropathy,DN）是糖尿病（diabetic mellitus,DM）患者常见的微血管并发症之一。近年来的研究提示氧化应激在DN发生、发展过程中发挥重要作用。
作者 李黎 李勤 李世云
机构地区 成都大学附属医院内分泌科 遵义医学院
出处 《四川医学》 CAS 2011年第2期274-277,共4页 Sichuan Medical Journal
基金 四川省卫生厅科研项目(编号:080090)
关键词 糖尿病肾病 醛固酮受体拮抗剂 螺内酯 依普利酮 氧化应激
分类号 R587.2 [医药卫生—内分泌]
  • 相关文献

参考文献21

  • 1Hideyasu Kiyomoto,Kazi Rafiq.Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury[J].J Pharmacol Sci,2008,108:399 -405.
  • 2Thallas-Bonke V,Thorpe SR.Coughlan MT,et al.Inhibition of NADPH oxidase prevents AGE-mediated damage in diabetic nephropathy through a protein kinase Cdependent pathway[J].Diabetes,2007,57:460-469.
  • 3Satoh M,Fujimoto S,Haruna Y,et al.NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy[J].Am J Physiol Renal Physiol,2005,288:1144-1152.
  • 4Xu Y,Osbome BW,Stanton RC.Diabetes causes inhibition of glucose-6-phosphate dehydrogenasevia activation of protein kinase a which contributes to oxidative stress in rat kidney cortexp[J].Am J Physiol Renal Physiol,2005,289 (5):1040-1047.
  • 5贾汝汉,陈玲.氧化应激在糖尿病肾病发病中的作用(上)[J].中国中西医结合肾病杂志,2006,7(8):373-375. 被引量：8
  • 6邹丽霞,谷卫.环氧化酶-2与糖尿病[J].国际内分泌代谢杂志,2006,26(1):45-47. 被引量：11
  • 7Thallas-Bonke V,Thorpe SR.Inhibition of NADPH oxidase preventsadvanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway[J].Diabetes,2008,57:460-469.
  • 8Shirong Zheng,Edward C.Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy[J].J Am Soc Nephrol,2008,19:2077 -2085.
  • 9Sato A,Hayashi K,Naruse M,et al.Effectiveness of aldosterone blockade in patient with diabetic nephropathy[J].Hypertension,2003,41 (l):64-68.
  • 10任野平,阮颖新,朱忠华.安体舒通对单侧输尿管结扎大鼠肾脏的抗氧化保护作用[J].南京医科大学学报（自然科学版）,2007,27(10):1130-1133. 被引量：3

二级参考文献55

  • 1姜宗培,余学清,陈雄辉,杨念生,河宪珠,李熙渤.转化生长因子β1对系膜细胞纤溶酶原激活物抑制物1表达的影响[J].中华肾脏病杂志,2004,20(4):260-263. 被引量：11
  • 2方展,朱忠华,张春,熊京.螺内酯对梗阻性肾病大鼠肾间质纤维化的防治作用[J].中华肾脏病杂志,2006,22(1):50-52. 被引量：12
  • 3CHABRASHVILI T,TOJO A,ONOZATO ML,et al.Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney[J].Hypertension,2002,39(2):269-274.
  • 4CHABRASHVILI T,KITIYAKARA C,BLAU J,et al.Effects of ANG Ⅱ type 1 and 2 receptors on oxidative stress,renal NADPH oxidase,and SOD expression[J].Am J Physiol Regul Integr Comp Phisiol,2003,285(1):R117-R124.
  • 5GATE L,PAUL J,BA GN,et al.Oxidative stress induced in pathologies:the role of antioxidants[J].Biomed Pharmacother,1999,53(4):169-180.
  • 6DELBOSC S,CRISTOL JP,DESCOMPS B,et al.Oxygen and the superoxide anion.Modulation of NADPH oxidase?[J].J Soc Biol,2001,195(4):401-411.
  • 7ZHANG H,SCR A,GARLICHS CD,et al.Angiotensin Ⅱ-induced superoxide anion generation in human vascular endothelial cells:role of membrane-bound NADH-/NADPH-oxidases[J].Cardiovasc Res,1999,44(1):215-222.
  • 8SUN Y,ZHANG J,LU L,et al.Aldosterone-induced inflammation in the rat heart:role of oxidative stress[J].AmJPathol,2002,161(5):1773-1781.
  • 9VIRDIS A,NEVES MF,AMIRI F,et al.Spironolactone improves angiotensin-induced vascular changes and oxidative stress[J],Hypertension,2002,40(4):504-510.
  • 10EL Nahas AN.Pathways to renal fibrosis[J].Exp Nephrol,1995,3:71-75.

共引文献27

同被引文献26

  • 1王德琴,施辉.螺内酯与缬沙坦联合治疗对早期糖尿病肾病尿白蛋白排泄率的影响[J].实用医学杂志,2009,25(5):790-791. 被引量：11
  • 2Guo LL,Pan Y,Jin HM.Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensinⅡtype 1 receptor blocker losarton[J].Nephrol Dial Transplant,2009,24(6):1876-1883.
  • 3Sato A,Hayashi K,Naruse M,et al.Effectiveness of aldosterone blockade in patients with diabetic nephropathy[J].Hyprtension,2003,41(1):64-68.
  • 4Bomback AS,Kshirsagar AV,Amamoo MA,et al.Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD:a systematic review[J].Am J Kidney Dis,2008,51(2):199-211.
  • 5Sviglerova J.Streptozotocin-induced model of type l diabetes mellitus[J].Cesk Fysiol,2006,55(3):96-102.
  • 6Hideyasu Kiyomoto,Kazi Rafiq.Possible underlying machanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury[J].J Pharmacol Sci,2008,108(4):399-405.
  • 7Whaley-connell A,Habibi J,Wei Y,et al.Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren 2 rat[J].Am J Physiol Rwnal Physiol,2009,296(5)1013-1022.
  • 8Marcin Renke,Leszek Tylicki,Narcyz Knap,et al.Spironolactoen attenuates oxidative stress in patients with chronic kidney diseases[J].Hypertension,2008,52:132-133.
  • 9Ianchi,S,bigazzi R.Campese VM.Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease[J].Kidney Int,2006,70:2116-2123.
  • 10陈红梅,蒋霞.螺内酯联合依那普利治疗早期糖尿病肾病的疗效观察[J].实用医药杂志,2010,27(3):214-215. 被引量：5

引证文献5

二级引证文献28

四川医学
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部